Cellebrite Announces “Redemption Fair Market Value” in Connection with Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the […]
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the […]
NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a […]
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of […]
ZEELAND, Mich., Aug. 30, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected […]
New York, NY, Aug. 30, 2024 (GLOBE NEWSWIRE) — Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the “Company”) announced that it has […]
SAN DIEGO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]
STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to […]
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced […]
WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, […]
TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Mulvihill Premium Yield Fund (the “Fund”) (TSX: MPY) announces results of operations for […]